Global Talazoparib Market Growth 2022-2028
- LP 4768504
- 78 Pages
- January 2022
- Pharmaceuticals
The United States Talazoparib market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Talazoparib market, reaching US$ million by the year 2028. As for the Europe Talazoparib landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Talazoparib players cover Pfizer, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Talazoparib market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
0.25mg Capsules
1mg Capsules
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Drug Center
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Talazoparib Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Talazoparib by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Talazoparib by Country/Region, 2017, 2022 & 2028
2.2 Talazoparib Segment by Type
2.2.1 0.25mg Capsules
2.2.2 1mg Capsules
2.3 Talazoparib Sales by Type
2.3.1 Global Talazoparib Sales Market Share by Type (2017-2022)
2.3.2 Global Talazoparib Revenue and Market Share by Type (2017-2022)
2.3.3 Global Talazoparib Sale Price by Type (2017-2022)
2.4 Talazoparib Segment by Application
2.4.1 Hospital
2.4.2 Drug Center
2.4.3 Clinic
2.4.4 Other
2.5 Talazoparib Sales by Application
2.5.1 Global Talazoparib Sale Market Share by Application (2017-2022)
2.5.2 Global Talazoparib Revenue and Market Share by Application (2017-2022)
2.5.3 Global Talazoparib Sale Price by Application (2017-2022)
3 Global Talazoparib by Company
3.1 Global Talazoparib Breakdown Data by Company
3.1.1 Global Talazoparib Annual Sales by Company (2020-2022)
3.1.2 Global Talazoparib Sales Market Share by Company (2020-2022)
3.2 Global Talazoparib Annual Revenue by Company (2020-2022)
3.2.1 Global Talazoparib Revenue by Company (2020-2022)
3.2.2 Global Talazoparib Revenue Market Share by Company (2020-2022)
3.3 Global Talazoparib Sale Price by Company
3.4 Key Manufacturers Talazoparib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Talazoparib Product Location Distribution
3.4.2 Players Talazoparib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Talazoparib by Geographic Region
4.1 World Historic Talazoparib Market Size by Geographic Region (2017-2022)
4.1.1 Global Talazoparib Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Talazoparib Annual Revenue by Geographic Region
4.2 World Historic Talazoparib Market Size by Country/Region (2017-2022)
4.2.1 Global Talazoparib Annual Sales by Country/Region (2017-2022)
4.2.2 Global Talazoparib Annual Revenue by Country/Region
4.3 Americas Talazoparib Sales Growth
4.4 APAC Talazoparib Sales Growth
4.5 Europe Talazoparib Sales Growth
4.6 Middle East & Africa Talazoparib Sales Growth
5 Americas
5.1 Americas Talazoparib Sales by Country
5.1.1 Americas Talazoparib Sales by Country (2017-2022)
5.1.2 Americas Talazoparib Revenue by Country (2017-2022)
5.2 Americas Talazoparib Sales by Type
5.3 Americas Talazoparib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Talazoparib Sales by Region
6.1.1 APAC Talazoparib Sales by Region (2017-2022)
6.1.2 APAC Talazoparib Revenue by Region (2017-2022)
6.2 APAC Talazoparib Sales by Type
6.3 APAC Talazoparib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Talazoparib by Country
7.1.1 Europe Talazoparib Sales by Country (2017-2022)
7.1.2 Europe Talazoparib Revenue by Country (2017-2022)
7.2 Europe Talazoparib Sales by Type
7.3 Europe Talazoparib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Talazoparib by Country
8.1.1 Middle East & Africa Talazoparib Sales by Country (2017-2022)
8.1.2 Middle East & Africa Talazoparib Revenue by Country (2017-2022)
8.2 Middle East & Africa Talazoparib Sales by Type
8.3 Middle East & Africa Talazoparib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Talazoparib
10.3 Manufacturing Process Analysis of Talazoparib
10.4 Industry Chain Structure of Talazoparib
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Talazoparib Distributors
11.3 Talazoparib Customer
12 World Forecast Review for Talazoparib by Geographic Region
12.1 Global Talazoparib Market Size Forecast by Region
12.1.1 Global Talazoparib Forecast by Region (2023-2028)
12.1.2 Global Talazoparib Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Talazoparib Forecast by Type
12.7 Global Talazoparib Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Talazoparib Product Offered
13.1.3 Pfizer Talazoparib Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
14 Research Findings and Conclusion
Table 1. Talazoparib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Talazoparib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 0.25mg Capsules
Table 4. Major Players of 1mg Capsules
Table 5. Global Talazoparib Sales by Type (2017-2022) & (K Pcs)
Table 6. Global Talazoparib Sales Market Share by Type (2017-2022)
Table 7. Global Talazoparib Revenue by Type (2017-2022) & ($ million)
Table 8. Global Talazoparib Revenue Market Share by Type (2017-2022)
Table 9. Global Talazoparib Sale Price by Type (2017-2022) & (USD/Pcs)
Table 10. Global Talazoparib Sales by Application (2017-2022) & (K Pcs)
Table 11. Global Talazoparib Sales Market Share by Application (2017-2022)
Table 12. Global Talazoparib Revenue by Application (2017-2022)
Table 13. Global Talazoparib Revenue Market Share by Application (2017-2022)
Table 14. Global Talazoparib Sale Price by Application (2017-2022) & (USD/Pcs)
Table 15. Global Talazoparib Sales by Company (2020-2022) & (K Pcs)
Table 16. Global Talazoparib Sales Market Share by Company (2020-2022)
Table 17. Global Talazoparib Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Talazoparib Revenue Market Share by Company (2020-2022)
Table 19. Global Talazoparib Sale Price by Company (2020-2022) & (USD/Pcs)
Table 20. Key Manufacturers Talazoparib Producing Area Distribution and Sales Area
Table 21. Players Talazoparib Products Offered
Table 22. Talazoparib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Talazoparib Sales by Geographic Region (2017-2022) & (K Pcs)
Table 26. Global Talazoparib Sales Market Share Geographic Region (2017-2022)
Table 27. Global Talazoparib Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Talazoparib Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Talazoparib Sales by Country/Region (2017-2022) & (K Pcs)
Table 30. Global Talazoparib Sales Market Share by Country/Region (2017-2022)
Table 31. Global Talazoparib Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Talazoparib Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Talazoparib Sales by Country (2017-2022) & (K Pcs)
Table 34. Americas Talazoparib Sales Market Share by Country (2017-2022)
Table 35. Americas Talazoparib Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Talazoparib Revenue Market Share by Country (2017-2022)
Table 37. Americas Talazoparib Sales by Type (2017-2022) & (K Pcs)
Table 38. Americas Talazoparib Sales Market Share by Type (2017-2022)
Table 39. Americas Talazoparib Sales by Application (2017-2022) & (K Pcs)
Table 40. Americas Talazoparib Sales Market Share by Application (2017-2022)
Table 41. APAC Talazoparib Sales by Region (2017-2022) & (K Pcs)
Table 42. APAC Talazoparib Sales Market Share by Region (2017-2022)
Table 43. APAC Talazoparib Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Talazoparib Revenue Market Share by Region (2017-2022)
Table 45. APAC Talazoparib Sales by Type (2017-2022) & (K Pcs)
Table 46. APAC Talazoparib Sales Market Share by Type (2017-2022)
Table 47. APAC Talazoparib Sales by Application (2017-2022) & (K Pcs)
Table 48. APAC Talazoparib Sales Market Share by Application (2017-2022)
Table 49. Europe Talazoparib Sales by Country (2017-2022) & (K Pcs)
Table 50. Europe Talazoparib Sales Market Share by Country (2017-2022)
Table 51. Europe Talazoparib Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Talazoparib Revenue Market Share by Country (2017-2022)
Table 53. Europe Talazoparib Sales by Type (2017-2022) & (K Pcs)
Table 54. Europe Talazoparib Sales Market Share by Type (2017-2022)
Table 55. Europe Talazoparib Sales by Application (2017-2022) & (K Pcs)
Table 56. Europe Talazoparib Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Talazoparib Sales by Country (2017-2022) & (K Pcs)
Table 58. Middle East & Africa Talazoparib Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Talazoparib Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Talazoparib Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Talazoparib Sales by Type (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Talazoparib Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Talazoparib Sales by Application (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Talazoparib Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Talazoparib
Table 66. Key Market Challenges & Risks of Talazoparib
Table 67. Key Industry Trends of Talazoparib
Table 68. Talazoparib Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Talazoparib Distributors List
Table 71. Talazoparib Customer List
Table 72. Global Talazoparib Sales Forecast by Region (2023-2028) & (K Pcs)
Table 73. Global Talazoparib Sales Market Forecast by Region
Table 74. Global Talazoparib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Talazoparib Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Talazoparib Sales Forecast by Country (2023-2028) & (K Pcs)
Table 77. Americas Talazoparib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Talazoparib Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. APAC Talazoparib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Talazoparib Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Europe Talazoparib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Talazoparib Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Middle East & Africa Talazoparib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Talazoparib Sales Forecast by Type (2023-2028) & (K Pcs)
Table 85. Global Talazoparib Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Talazoparib Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Talazoparib Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Talazoparib Sales Forecast by Application (2023-2028) & (K Pcs)
Table 89. Global Talazoparib Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Talazoparib Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Talazoparib Revenue Market Share Forecast by Application (2023-2028)
Table 92. Pfizer Basic Information, Talazoparib Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Talazoparib Product Offered
Table 94. Pfizer Talazoparib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments
List of Figures
Figure 1. Picture of Talazoparib
Figure 2. Talazoparib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Talazoparib Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Talazoparib Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Talazoparib Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 0.25mg Capsules
Figure 10. Product Picture of 1mg Capsules
Figure 11. Global Talazoparib Sales Market Share by Type in 2021
Figure 12. Global Talazoparib Revenue Market Share by Type (2017-2022)
Figure 13. Talazoparib Consumed in Hospital
Figure 14. Global Talazoparib Market: Hospital (2017-2022) & (K Pcs)
Figure 15. Talazoparib Consumed in Drug Center
Figure 16. Global Talazoparib Market: Drug Center (2017-2022) & (K Pcs)
Figure 17. Talazoparib Consumed in Clinic
Figure 18. Global Talazoparib Market: Clinic (2017-2022) & (K Pcs)
Figure 19. Talazoparib Consumed in Other
Figure 20. Global Talazoparib Market: Other (2017-2022) & (K Pcs)
Figure 21. Global Talazoparib Sales Market Share by Application (2017-2022)
Figure 22. Global Talazoparib Revenue Market Share by Application in 2021
Figure 23. Talazoparib Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Talazoparib Revenue Market Share by Company in 2021
Figure 25. Global Talazoparib Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Talazoparib Revenue Market Share by Geographic Region in 2021
Figure 27. Global Talazoparib Sales Market Share by Region (2017-2022)
Figure 28. Global Talazoparib Revenue Market Share by Country/Region in 2021
Figure 29. Americas Talazoparib Sales 2017-2022 (K Pcs)
Figure 30. Americas Talazoparib Revenue 2017-2022 ($ Millions)
Figure 31. APAC Talazoparib Sales 2017-2022 (K Pcs)
Figure 32. APAC Talazoparib Revenue 2017-2022 ($ Millions)
Figure 33. Europe Talazoparib Sales 2017-2022 (K Pcs)
Figure 34. Europe Talazoparib Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Talazoparib Sales 2017-2022 (K Pcs)
Figure 36. Middle East & Africa Talazoparib Revenue 2017-2022 ($ Millions)
Figure 37. Americas Talazoparib Sales Market Share by Country in 2021
Figure 38. Americas Talazoparib Revenue Market Share by Country in 2021
Figure 39. United States Talazoparib Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Talazoparib Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Talazoparib Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Talazoparib Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Talazoparib Sales Market Share by Region in 2021
Figure 44. APAC Talazoparib Revenue Market Share by Regions in 2021
Figure 45. China Talazoparib Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Talazoparib Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Talazoparib Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Talazoparib Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Talazoparib Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Talazoparib Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Talazoparib Sales Market Share by Country in 2021
Figure 52. Europe Talazoparib Revenue Market Share by Country in 2021
Figure 53. Germany Talazoparib Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Talazoparib Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Talazoparib Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Talazoparib Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Talazoparib Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Talazoparib Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Talazoparib Revenue Market Share by Country in 2021
Figure 60. Egypt Talazoparib Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Talazoparib Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Talazoparib Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Talazoparib Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Talazoparib Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Talazoparib in 2021
Figure 66. Manufacturing Process Analysis of Talazoparib
Figure 67. Industry Chain Structure of Talazoparib
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
